NVAX Financial Facts
General and administrative: 13.56MRevenue: 102K
See Full Income Statement
Total liabilities and stockholders' equity: 459.63M
Current portion of notes payable: 45K
See Full Balance Sheet
Novavax, Inc. (NVAX) Earnings
|
Expand Research on NVAX
| Next EPS Date | 8/12/26 | EPS Growth Rate | -164.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +528.0% | Revenue Growth Rate | -78.2% |
| Average % Move 1-Wk after EPS | +11.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.40 | N/A | N/A | $52.06M | = | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.06 | -$0.24 | +$0.18 | $139.51M | $79.31M | = |  | | Details | |
| 2/26/26 |
Q425 | $0.11 | -$0.49 | +$0.60 | $147M | $90.25M | = | | | Details | |
| 11/6/25 |
Q325 | N/A | -$0.54 | N/A | N/A | $55.66M | = | N/A | N/A | ||
| 8/6/25 | Q225 | $0.62 | -$0.06 | +$0.68 | $239M | $156.23M | = | | | Details | |
| 5/8/25 |
Q125 | $2.93 | -$0.43 | +$3.36 | $667M | $251.8M | = | | | Details | |
| 2/27/25 | Q424 | -$0.51 | -$0.60 | +$0.09 | $88.31M | $102.74M | = | | | Details | |
| 11/12/24 | Q324 | -$0.76 | -$0.83 | +$0.07 | $85M | $65.8M | = | | | Details |
